Literature DB >> 2419156

Recovery and measurement of specific RNA species from postmortem brain tissue: a general reduction in Alzheimer's disease detected by molecular hybridization.

G R Taylor, G I Carter, T J Crow, J A Johnson, A F Fairbairn, E K Perry, R H Perry.   

Abstract

The recovery of RNA from postmortem (PM) brain tissues was quantified by molecular hybridization. RNA degradation rates postmortem were faster in mice with herpes encephalitis than with uninfected mice, but clear ribosomal peaks could be seen up to 72 hr after death. In a comparison between frontal cortex samples from neurologically normal and Alzheimer's disease cases a reduction in ribosomal, poly A, preproenkephalin, and preprosomatostatin RNA levels was observed in the Alzheimer's disease group. This general reduction may be influenced by the cause of death as well as the pathology.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2419156     DOI: 10.1016/0014-4800(86)90038-9

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  10 in total

1.  The expression of several mitochondrial and nuclear genes encoding the subunits of electron transport chain enzyme complexes, cytochrome c oxidase, and NADH dehydrogenase, in different brain regions in Alzheimer's disease.

Authors:  M Y Aksenov; H M Tucker; P Nair; M V Aksenova; D A Butterfield; S Estus; W R Markesbery
Journal:  Neurochem Res       Date:  1999-06       Impact factor: 3.996

2.  A study on postmortem stability of vasopressin messenger RNA in rat brain compared with those in total RNA and ribosomal RNA.

Authors:  I Noguchi; H Arai; R Iizuka
Journal:  J Neural Transm Gen Sect       Date:  1991

3.  Aluminum, altered transcription, and the pathogenesis of Alzheimer's disease.

Authors:  D R Crapper McLachlan; W J Lukiw; T P Kruck
Journal:  Environ Geochem Health       Date:  1990-03       Impact factor: 4.609

4.  Localization of neuropeptide Y mRNA in neurons of human cerebral cortex by means of in situ hybridization with a complementary RNA probe.

Authors:  G Terenghi; J M Polak; Q Hamid; E O'Brien; P Denny; S Legon; J Dixon; C D Minth; S L Palay; G Yasargil
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

Review 5.  The molecular mechanisms of scrapie encephalopathy and relevance to human neurodegenerative disease.

Authors:  W J Lukiw; H J Cho; J C Kaufmann; D R Crapper McLachlan
Journal:  Can J Vet Res       Date:  1990-01       Impact factor: 1.310

6.  The expression of key oxidative stress-handling genes in different brain regions in Alzheimer's disease.

Authors:  M Y Aksenov; H M Tucker; P Nair; M V Aksenova; D A Butterfield; S Estus; W R Markesbery
Journal:  J Mol Neurosci       Date:  1998-10       Impact factor: 3.444

7.  BC200 RNA in normal human neocortex, non-Alzheimer dementia (NAD), and senile dementia of the Alzheimer type (AD).

Authors:  W J Lukiw; P Handley; L Wong; D R Crapper McLachlan
Journal:  Neurochem Res       Date:  1992-06       Impact factor: 3.996

8.  Methodological considerations for gene expression profiling of human brain.

Authors:  Mary Atz; David Walsh; Preston Cartagena; Jun Li; Simon Evans; Prabhakara Choudary; Kevin Overman; Richard Stein; Hiro Tomita; Steven Potkin; Rick Myers; Stanley J Watson; E G Jones; Huda Akil; William E Bunney; Marquis P Vawter
Journal:  J Neurosci Methods       Date:  2007-04-08       Impact factor: 2.390

9.  Astrocyte RNA in relation to neuronal RNA depletion in Alzheimer's disease.

Authors:  J A Doebler; W R Markesbery; A Anthony; S W Scheff; R E Rhoads
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

10.  Polyadenylated messenger RNA in paired helical filament-immunoreactive neurons in Alzheimer disease.

Authors:  W S Griffin; C Ling; C L White; M Morrison-Bogorad
Journal:  Alzheimer Dis Assoc Disord       Date:  1990       Impact factor: 2.703

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.